Neurobehavioral effects of recombinant human erythropoietin A. R. Nissenson, MD

Subcutaneous versus intravenous administration of human recombinant erythropoietin in patients on chronic hemodialysis U. Barnas, U. Watzinger, G. Peer, G. Mayer y H. Graf.

The anemia of chronic renal failure: Pathophysiology and treatment with recombinant human erythropoietin J. W. Adamson and J. W. Eschbach